RxDoctor Payments Data

Richy Agajanian

Hematology & Oncology · Downey, CANPI 1922116664

Payments from drug & device makers

$2,726,087in general payments, 2019–2025

Across 362 payments — averaging $7530.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acerta Pharma LLC$956K
  • Eli Lilly$656K
  • Pfizer$288K
  • E.r. Squibb & Sons, L.L.C.$278K
  • EMD Serono, Inc.$228K
  • Takeda Pharmaceuticals U.S.A., Inc.$55K
  • plus $265K from 18 others
$19,309in research payments, 2019–2025

Across 5 payments — averaging $3861.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aurobindo Pharma USA, Inc.$10K
  • Rigel Pharmaceuticals, Inc.$7K
  • Bristol Myers Squibb$2K
  • TG Therapeutics, Inc.$16

What the payments were for

  • Consulting fees$22529%
  • Food & beverage$8911%
  • Other$46860%

General payments by program year

19
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,726,087 in reported general payments places this provider in the 90th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Downey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →